These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases. ter Heine R; Lange R; Breukels OB; Bloemendal HJ; Rummenie RG; Wakker AM; de Graaf H; Beekman FJ; van der Westerlaken MM; Malingré MM; Wielders JP; van den Berg L; Hendrikse NH; de Klerk JM Int J Pharm; 2014 Apr; 465(1-2):317-24. PubMed ID: 24560635 [TBL] [Abstract][Full Text] [Related]
23. 188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases. El-Mabhouh AA; Mercer JR Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1240-8. PubMed ID: 18265977 [TBL] [Abstract][Full Text] [Related]
24. Cancer therapy using bone-seeking isotopes. Lewington VJ Phys Med Biol; 1996 Oct; 41(10):2027-42. PubMed ID: 8912378 [TBL] [Abstract][Full Text] [Related]
25. 188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases. El-Mabhouh A; Mercer JR Appl Radiat Isot; 2005 Apr; 62(4):541-9. PubMed ID: 15701408 [TBL] [Abstract][Full Text] [Related]
26. 188Re-ethylene dicysteine: a novel agent for possible use in endovascular radiation therapy. Das T; Banerjee S; Samuel G; Sarma HD; Ramamoorthy N; Pillai MR Nucl Med Commun; 2000 Oct; 21(10):939-45. PubMed ID: 11130335 [TBL] [Abstract][Full Text] [Related]
27. Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals. Ogawa K; Mukai T; Arano Y; Ono M; Hanaoka H; Ishino S; Hashimoto K; Nishimura H; Saji H Bioconjug Chem; 2005; 16(4):751-7. PubMed ID: 16029015 [TBL] [Abstract][Full Text] [Related]
28. The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain. Liepe K; Runge R; Kotzerke J J Cancer Res Clin Oncol; 2005 Jan; 131(1):60-6. PubMed ID: 15449184 [TBL] [Abstract][Full Text] [Related]
29. Assessment of 186Re chelate-conjugated bisphosphonate for the development of new radiopharmaceuticals for bones. Uehara T; Jin ZL; Ogawa K; Akizawa H; Hashimoto K; Nakayama M; Arano Y Nucl Med Biol; 2007 Jan; 34(1):79-87. PubMed ID: 17210464 [TBL] [Abstract][Full Text] [Related]
30. Comparison of various rhenium-188-labeled diphosphonates for the treatment of bone metastases. Hsieh BT; Hsieh JF; Tsai SC; Lin WY; Wang SJ; Ting G Nucl Med Biol; 1999 Nov; 26(8):973-6. PubMed ID: 10708313 [TBL] [Abstract][Full Text] [Related]
31. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients. Sciuto R; Festa A; Pasqualoni R; Semprebene A; Rea S; Bergomi S; Maini CL Breast Cancer Res Treat; 2001 Mar; 66(2):101-9. PubMed ID: 11437096 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases. Liepe K; Kropp J; Runge R; Kotzerke J Br J Cancer; 2003 Aug; 89(4):625-9. PubMed ID: 12915868 [TBL] [Abstract][Full Text] [Related]
36. 186Re-HEDP for metastatic bone pain in breast cancer patients. Lam MG; de Klerk JM; van Rijk PP Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S162-70. PubMed ID: 15118846 [TBL] [Abstract][Full Text] [Related]
37. 186Re-etidronate. Efficacy of palliative radionuclide therapy for painful bone metastases. Han SH; De Klerk JM; Zonnenberg BA; Tan S; Van Rijk PP Q J Nucl Med; 2001 Mar; 45(1):84-90. PubMed ID: 11456380 [TBL] [Abstract][Full Text] [Related]
38. 177Lu-EDTMP: a potential therapeutic bone agent. Ando A; Ando I; Tonami N; Kinuya S; Kazuma K; Kataiwa A; Nakagawa M; Fujita N Nucl Med Commun; 1998 Jun; 19(6):587-91. PubMed ID: 10234664 [TBL] [Abstract][Full Text] [Related]
39. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds. Knapp FF; Guhlke S; Beets AL; Lin WY; Stabin M; Amols H; Weinberger J Cardiovasc Radiat Med; 1999; 1(1):86-97. PubMed ID: 11272362 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastases. de Klerk JM; van Dijk A; van het Schip AD; Zonnenberg BA; van Rijk PP J Nucl Med; 1992 May; 33(5):646-51. PubMed ID: 1373767 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]